Bristol-Myers Squibb (BMY) wins FDA nod to expand the U.S. label for its blockbuster immunotherapy Opdivo in lung cancer
https://seekingalpha.com/news/4156093-bristol-myers-stock-up-fda-expands-opdivo-label
Bristol-Myers Squibb (BMY) wins FDA nod to expand the U.S. label for its blockbuster immunotherapy Opdivo in lung cancer
https://seekingalpha.com/news/4156093-bristol-myers-stock-up-fda-expands-opdivo-label
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.